Literature DB >> 1693801

Sendai virus gene expression in lytically and persistently infected cells.

H E Homann1, P H Hofschneider, W J Neubert.   

Abstract

Sendai virus RNA species were quantitated in lytically and persistently infected cultured cells by Northern blot hybridization to region- and strand-specific cloned cDNA probes. Levels of NP, P and M mRNA in lytically infected cells were equally high, but F and HN mRNA were present in about 3-fold, and L mRNA in 30-fold, lower amounts, reflecting transcriptional attenuation especially at the M-F and HN-L gene junction. Two persistently infected cell lines, which release only 1% of the virus particles of lytically infected cells, were shown to contain only 4- to 8-fold-less amounts of each viral mRNA and 2- to 3-fold-less genomic RNA than lytically infected cells. Additionally, transcription was neither defective nor more attenuated as compared to the lytical infection. Taken together the results suggest the existence of an additional regulatory mechanism for the virus release. A cell-associated state of infection therefore seems to be achievable by a relatively weak general reduction of the copy numbers of viral mRNA and genomic RNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693801     DOI: 10.1016/0042-6822(90)90467-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes.

Authors:  Peter H Goff; Qinshan Gao; Peter Palese
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 3.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

4.  Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein.

Authors:  H E Homann; W Willenbrink; C J Buchholz; W J Neubert
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Authors:  Carolina Johnstone; Elena Lorente; Alejandro Barriga; Eilon Barnea; Susana Infantes; François A Lemonnier; Chella S David; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2015-01-29       Impact factor: 5.911

6.  Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.

Authors:  Christine Krempl; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.

Authors:  Matthias Lingemann; Sonja Surman; Emérito Amaro-Carambot; Anne Schaap-Nutt; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

8.  Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis.

Authors:  Geneviève Mottet-Osman; Frédéric Iseni; Thierry Pelet; Maciej Wiznerowicz; Dominique Garcin; Laurent Roux
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

9.  A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

Authors:  Jason P Roth; Joseph K-K Li; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2009-02-02       Impact factor: 5.970

10.  Model for polymerase access to the overlapped L gene of respiratory syncytial virus.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.